文献速递瓣膜病与结构性心脏病

经导管主动脉瓣植入术围术期麻醉策略:多中心随机对照非劣效性试验

Peri-Interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Noninferiority Trial.
PubMed 文献 · Circulation · 2025-08-29

DOUBLE-CHOICE 试验在 10 家德国中心纳入 752 例有症状主动脉瓣狭窄患者,随机比较极简麻醉(单纯局部麻醉)与标准麻醉(清醒镇静)用于经股动脉 TAI 的安全性和有效性。主要终点为 30 天全因死亡、血管与出血并发症、需抗生素治疗的感染及神经事件的复合终点。极简麻醉组主要终点发生率为 22.9%,标准麻醉组为 25.8%,率差 2.9%(单侧 95%CI 下限 -2.4%,非劣效 P=0.003),达到非劣效。极简麻醉组术中患者报告的焦虑和应激水平更高。

要点

  • 极简麻醉(单纯局部麻醉)在 30 天复合终点上非劣效于清醒镇静。
  • 极简麻醉组术中疼痛与不适负担可能更高。
  • 研究结果为经股动脉 TAVI 采用极简麻醉策略提供了随机证据。

核心结论

  • 包含单纯局部麻醉的极简麻醉策略在 30 天复合终点上非劣效于清醒镇静的标准麻醉策略。
  • 极简麻醉组术中患者报告的焦虑和应激水平更高。

研究设计与样本

  • 研究者发起的 2×2 析因、开放标签、随机、多中心、非劣效性试验,在 10 家德国中心纳入有症状主动脉瓣狭窄患者。
  • 752 例患者随机分配至极简麻醉组(n=377)和标准麻醉组(n=375)。
  • 中位年龄 83 岁(IQR 79-86),439 例(58.5%)为女性,中位 STS 风险评分 4.6%(IQR 2.9-8.0)。

主要发现

  • 主要终点在极简麻醉组 350 例中发生 80 例(22.9%),标准麻醉组 353 例中发生 91 例(25.8%)。
  • 率差 2.9%,单侧 95%CI 下限 -2.4%,非劣效 P=0.003;双侧 95%CI -3.4 至 9.3,组间差异 P=0.37。
  • 极简麻醉组术中患者报告的焦虑和应激水平更高。

关键数值与推荐

  • 主要终点为 30 天全因死亡、血管与出血并发症、需抗生素治疗的感染及神经事件的复合终点。
  • 非劣效性在意向治疗人群中检验,绝对非劣效界值为 -6%,α 水平 0.05。

临床怎么用

  • 经股动脉 TAVI 可考虑采用包含单纯局部麻醉的极简麻醉策略。
  • 需关注极简麻醉组术中疼痛与不适负担可能更高的问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimalist treatment strategies for transcatheter aortic valve implantation have been widely adopted because of continued procedural evolution, but large randomized trials are lacking. The DOUBLE-CHOICE trial (Randomized Study Comparing Both Latest Generation Self-Expanding Valves and a Minimalist Approach Versus Standard of Care in Transcatheter Aortic Valve Implantation) evaluated the safety and efficacy of a minimalist approach (MA) compared with the standard of care (SoC) for transfemoral transcatheter aortic valve implantation. METHODS: In this investigator-initiated, 2×2 factorial, open-label, randomized, multicenter, noninferiority trial, patients with symptomatic aortic stenosis were included at 10 German sites. Patients were randomly assigned to the MA, including isolated local anesthesia, versus the SoC using conscious sedation. The primary end point was a composite of all-cause mortality, vascular and bleeding complications, infection requiring antibiotic therapy, and neurological events at 30 days. The noninferiority of the MA compared with the SoC was tested in the intention-to-treat population with an absolute noninferiority margin of -6% at an α level of 0.05. RESULTS: Between July 11, 2022, and January 14, 2025, 752 patients were randomly assigned to the MA (n=377) and SoC (n=375). The median age was 83 (interquartile range, 79-86) years, 439 (58.5%) patients were women, and the median Society of Thoracic Surgeons risk score was 4.6% (interquartile range, 2.9-8.0). The primary end point occurred in 80 (22.9%) of 350 patients in the MA group and in 91 (25.8%) of 353 patients in the SoC group (rate difference, 2.9%; lower boundary of the 1-sided 95% CI, -2.4%; P for noninferiority=0.003; 2-sided 95% CI, -3.4 to 9.3; P for difference=0.37). Patient-reported anxiety and stress levels during the procedure were higher in the MA group. CONCLUSIONS: The MA including isolated local anesthesia was noninferior to the SoC with conscious sedation, highlighting the safety and efficacy of the MA for transcatheter aortic valve implantation. The burden of intraprocedural pain and discomfort is potentially higher in the MA group. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT05036018.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Feistritzer HJ, Ender J, Lauten P, et al. Peri-Interventional Anesthesia Strategies for Transcatheter Aortic Valve Implantation: A Multicenter, Randomized, Controlled, Noninferiority Trial. Circulation. 2025. PMID: 40878766. doi:10.1161/CIRCULATIONAHA.125.076557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。